- Report
- November 2020
- 110 Pages
Mexico
From €3841EUR$3,995USD£3,295GBP
- Report
- October 2018
- 54 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- September 2023
- 200 Pages
Global
From €2884EUR$2,999USD£2,474GBP
- Report
- March 2022
- 172 Pages
Global
From €5931EUR$6,168USD£5,088GBP
- Report
- February 2021
- 109 Pages
United States
From €3508EUR$3,648USD£3,009GBP
- Book
- September 2022
- 480 Pages
- Book
- May 2021
- 640 Pages
- Book
- July 2020
- 464 Pages
- Book
- October 2019
- 184 Pages
- Book
- October 2019
China
- Book
- October 2018
- 354 Pages
China
- Book
- October 2018
China
The Cardiac Rhythm market is a subset of the Cardiology field that focuses on the diagnosis and treatment of heart rhythm disorders. It includes the development of medical devices, such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, as well as the use of drugs and other therapies to treat arrhythmias. The market also includes the use of non-invasive technologies, such as electrocardiography (ECG) and echocardiography, to diagnose and monitor cardiac rhythm disorders.
The Cardiac Rhythm market is a rapidly growing field, driven by advances in technology and the increasing prevalence of heart rhythm disorders. The market is expected to continue to grow in the coming years, as new treatments and technologies are developed and adopted.
Some of the major companies in the Cardiac Rhythm market include Medtronic, Abbott, Boston Scientific, Biotronik, and St. Jude Medical. Show Less Read more